We are live on ! Find out more
TBPH icon

Theravance Biopharma
TBPH

107 hedge funds and large institutions have $946M invested in Theravance Biopharma in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 32 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,800% more call options, than puts

Call options by funds: $69K | Put options by funds: $1K

22% more capital invested

Capital invested by funds: $775M → $946M (+$170M)

3% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 32

0.62% more ownership

Funds ownership: 82.6% → 83.21% (+0.62%)

9% less funds holding

Funds holding: 118 → 107 (-11)

42% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 26

Holders
107
Holders Change
-11
Holders Change %
-9.32%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
33
Reduced
32
Closed
26
Calls
$69K
Puts
$1K
Net Calls
+$68K
Net Calls Change
+$230K

Top Buyers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
+$14.8M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$13.3M
3
LCM
Laurion Capital Management
New York
+$11.2M
4
Morgan Stanley
Morgan Stanley
New York
+$8.39M
5
BlackRock
BlackRock
New York
+$3.08M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$10.3M
2
RCMNY
Rubric Capital Management (New York)
New York
-$8.14M
3
Norges Bank
Norges Bank
Norway
-$6.32M
4
RSCM
Rock Springs Capital Management
Maryland
-$2.62M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
76
Allstate Corporation
Illinois
$220K +$223K +12,407 New
AG
77
Aperio Group
California
$218K -$26.9K -1,496 -11%
HSBC Holdings
78
HSBC Holdings
United Kingdom
$212K – – –
II
79
Inspire Investing
Idaho
$208K +$210K +11,718 New
Susquehanna International Group
80
Susquehanna International Group
Pennsylvania
$197K -$449K -25,025 -69%
Public Employees Retirement Association of Colorado
81
Public Employees Retirement Association of Colorado
Colorado
$193K – – –
TAM
82
Tocqueville Asset Management
New York
$192K +$194K +10,800 New
CSS
83
Cubist Systematic Strategies
Connecticut
$190K +$192K +10,689 New
Invesco
84
Invesco
Georgia
$179K +$180K +10,033 New
BNP Paribas Financial Markets
85
BNP Paribas Financial Markets
France
$173K -$22.5K -1,255 -11%
Canada Pension Plan Investment Board
86
Canada Pension Plan Investment Board
Ontario, Canada
$169K – – –
Bank of Montreal
87
Bank of Montreal
Ontario, Canada
$127K +$85.9K +4,787 +171%
FMT
88
First Mercantile Trust
Tennessee
$104K – – –
Zurich Cantonal Bank
89
Zurich Cantonal Bank
Switzerland
$102K – – –
FTDI
90
First Trust Direct Indexing
Massachusetts
$93K +$94K +5,236 New
AIP
91
Ameritas Investment Partners
Nebraska
$76K – – –
Nisa Investment Advisors
92
Nisa Investment Advisors
Missouri
$68K +$2.03K +113 +3%
PCM
93
Penserra Capital Management
California
$26K +$16.6K +923 +170%
TRCT
94
Tower Research Capital (TRC)
New York
$25K -$627K -34,916 -96%
WT
95
Whittier Trust
California
$5K – – –
Osaic Holdings
96
Osaic Holdings
Arizona
$4K – – –
VCM
97
Versant Capital Management
Arizona
$4K – – –
PA
98
Parallel Advisors
California
$3K – – –
Daiwa Securities Group
99
Daiwa Securities Group
Japan
$2K -$4.09K -228 -66%
US Bancorp
100
US Bancorp
Minnesota
$2K +$2.08K +116 New
2 3
4
5 6

TBPH Hedge Fund Activity: Q4 2020 in Review

107 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Theravance Biopharma (TBPH) for Q4 2020, worth a combined $946M — up 22% from $775M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of TBPH and 15 opened new positions — a net loss of 11 holders — while 32 trimmed existing stakes and 33 added.

The largest buyer was Great Point Partners, opening a new position worth an estimated $14.8M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $10.3M sold.

  • 107 institutional investors held Theravance Biopharma (TBPH) as of Q4 2020, down from 118 in Q3 2020.
  • Funds reported $946M of Theravance Biopharma stock for Q4 2020, up 22% quarter-over-quarter.
  • 15 funds opened new Theravance Biopharma positions in Q4 2020 and 26 closed out, a net change of -11 holders.
  • The largest Theravance Biopharma buyer in Q4 2020 was Great Point Partners, an estimated $14.8M added.
  • The largest Theravance Biopharma seller in Q4 2020 was Adage Capital Partners, an estimated $10.3M sold.

Based on aggregated 13F filings for Q4 2020.